查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420394

全球水產養殖飼料和藥品市場-全球產業分析,規模,份額,成長,趨勢,預測 (2031) - 按產品類型、按類別、按地區

Aquaculture Feed and Pharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 202 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球水產養殖飼料和藥品市場規模將達9.994億美元。全球對這些產品的需求穩定，預計複合年增長率 (CAGR) 為 7.4%。因此，到 2031 年底，市場規模預計將達到 20 億美元。

由於藥品和生物製品領域的不斷進步和研究，全球水產養殖飼料和藥品市場預計到 2031 年將顯著成長。最近的市場分析顯示，藥品和生物製劑領域在價值和成長方面已成為該行業的主導力量，生物製劑細分領域在預測期內的複合年增長率達到驚人的7.7%，創歷史新高，預計將壓倒整個行業。其他的。

在各種產品類型中，藥品和生物製劑領域是最賺錢的領域，市場吸引力指數為1.6。相較之下，藥物飼料領域的吸引力預計最低，市場吸引力指數為 0.4。

該報告考察了全球水產養殖飼料和藥品市場，並提供了市場概況，包括按產品類型、物種、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第一章執行摘要

第二章市場概況

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第三章 2018-2031年全球水產養殖飼料及藥品市場展望

  • 2018-2031 年全球水產養殖飼料和藥品市場展望，按產品類型和價值（十億美元）劃分
  • 2018-2031 年全球水產養殖飼料和藥品市場展望、類型和價值（十億美元）
  • 全球水產養殖飼料和藥品市場展望，按地區，價值（十億美元），2018-2031

第四章 2018-2031年北美水產養殖飼料及藥品市場展望

第五章 2018-2031年歐洲水產養殖飼料及藥品市場展望

第六章 2018-2031 年亞太水產養殖飼料及藥品市場展望

第七章 2018-2031 年拉丁美洲水產養殖飼料與藥品市場展望

第八章 2018-2031年中東和非洲水產養殖飼料和藥品市場展望

第9章 競爭格局

  • 按產品類型和類型劃分的熱圖
  • 2023 年公司市場份額分析
  • 比賽儀表板
  • 公司簡介
    • Zoetis, Inc.
    • Schouw & Co
    • Ridley Corporation Ltd
    • Merck & Co Inc
    • Biomin Holding GmbH
    • Aller Aqua A/S
    • Nutriad Ltd.
    • Alltech Inc.
    • Avanti Feeds Ltd.
    • Norel S.A.
    • Cargill, Incorporated
    • Beneo GmbH
    • Skretting AS

第10章附錄

簡介目錄

The global market size for aquaculture feed and pharmaceuticals is currently estimated to be at US$ 999.4 million in 2024. It is anticipated that there will be a steady demand for these products worldwide, with a projected Compound Annual Growth Rate (CAGR) of 7.4%. As a result, the market is expected to reach a valuation of US$ 2 billion by the conclusion of 2031.

The global aquaculture feed and pharmaceuticals market is poised for significant growth through 2031, driven by continuous advancements and research in the field of pharmaceuticals and biologics. A recent market analysis indicates that the pharmaceutical and biologics segment will emerge as the dominant force in this industry, both in terms of value and growth with the biologics sub-segment expected to outperform others, boasting an impressive 7.7% compound annual growth rate (CAGR) during the forecast period.

Most Lucrative Segment with Strong Market Attractiveness

Among various product types, the pharmaceutical and biologics segment is set to be the most lucrative, boasting a market attractiveness index of 1.6. In contrast, the medicated feed segment is expected to be the least attractive, with a market attractiveness index of 0.4.

Driving Factors Behind Market Growth

Several factors are fueling the growth of the pharmaceutical and biologics segment in the aquaculture feed and pharmaceuticals market. There is a growing demand for structured research and development in the aquaculture field, particularly in biologics research. This has led to a faster introduction of drugs, medicated feed, and vaccines into regional markets, particularly in developed countries such as the United States and Canada. Such initiatives have stimulated inorganic growth through strategic partnerships and M&A activities among key industry players.

Key Trends and Developments

In the United States, the use of extra label drugs in aquaculture, under the guidance of licensed veterinarians, has opened up opportunities for the development of medicated feed and pharmaceuticals. Regulatory bodies, such as the FDA, support the use of approved extra label aquaculture medicated feeds, provided they meet compliance conditions. This development is expected to expand the scope for further advancements in medicated feed and pharmaceuticals for aquaculture.

Furthermore, the demand for in-feed medication as a prophylactic measure is on the rise in the global aquaculture feed and pharmaceutical market. The adoption of in-feed medication to prevent the spread of diseases among healthy fish is growing, particularly in organized fishing farms across Europe. This trend aligns with the limited use of antibiotics in the region.

Governmental Collaborations Drive R&D

Governments in various countries are initiating collaborative research and development efforts in partnership with regulatory bodies to enhance the availability of high-quality medicated feed and pharmaceuticals for aquaculture. As aquaculture becomes a crucial source of food for human consumption, the need for safe and effective treatments for various fish diseases has grown significantly.

Challenges Ahead

Despite the growth prospects, the lack of harmonization of veterinary medicinal products and medicated feed regulations across different regions, particularly in the European Union, poses challenges. Different laws for manufacturing veterinary medicines and medicated feed, along with varying residue limits of veterinary medicines in feed, hinder market estimation and forecasting efforts.

Competitive Analysis:

Some of the prominent players in the global market for aquaculture feed & pharmaceutical market are:

  • Zoetis, Inc.
  • Schouw & Co
  • Ridley Corporation Ltd
  • Merck & Co Inc
  • Biomin Holding GmbH
  • Aller Aqua A/S
  • Nutriad Ltd.
  • Alltech Inc.
  • Avanti Feeds Ltd.
  • Norel S.A.
  • Cargill, Incorporated
  • Beneo GmbH
  • Skretting AS
  • Novus International Inc.
  • Growel Feeds Pvt. Ltd.
  • Neovia Vietnam
  • Evonik Industries AG
  • Bayer AG
  • Koninklijke DSM N.V
  • Others.

Market Segmentation

Product Type

  • Pharmaceutical and Biologics

Anti-infectives

Parasiticides

Biologics

Others

  • Medicated Feed

Vitamins and Minerals

Amino Acids

Acidifiers

Others

Species

  • Molluscs
  • Shrimp
  • Salmons
  • Carps
  • Tilapia
  • Catfish
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Aquaculture Feed and Pharmaceutical Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 3.1. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Pharmaceutical and Biologics
        • 3.1.1.1.1. Anti-infectives
        • 3.1.1.1.2. Parasiticides
        • 3.1.1.1.3. Biologics
        • 3.1.1.1.4. Others
      • 3.1.1.2. Medicated Feed
        • 3.1.1.2.1. Vitamins and Minerals
        • 3.1.1.2.2. Amino Acids
        • 3.1.1.2.3. Acidifiers
        • 3.1.1.2.4. Others
  • 3.2. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Molluscs
      • 3.2.1.2. Shrimp
      • 3.2.1.3. Salmons
      • 3.2.1.4. Carps
      • 3.2.1.5. Tilapia
      • 3.2.1.6. Catfish
      • 3.2.1.7. Others
  • 3.3. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 4.1. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Pharmaceutical and Biologics
        • 4.1.1.1.1. Anti-infectives
        • 4.1.1.1.2. Parasiticides
        • 4.1.1.1.3. Biologics
        • 4.1.1.1.4. Others
      • 4.1.1.2. Medicated Feed
        • 4.1.1.2.1. Vitamins and Minerals
        • 4.1.1.2.2. Amino Acids
        • 4.1.1.2.3. Acidifiers
        • 4.1.1.2.4. Others
  • 4.2. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Molluscs
      • 4.2.1.2. Shrimp
      • 4.2.1.3. Salmons
      • 4.2.1.4. Carps
      • 4.2.1.5. Tilapia
      • 4.2.1.6. Catfish
      • 4.2.1.7. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 5.1. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Pharmaceutical and Biologics
        • 5.1.1.1.1. Anti-infectives
        • 5.1.1.1.2. Parasiticides
        • 5.1.1.1.3. Biologics
        • 5.1.1.1.4. Others
      • 5.1.1.2. Medicated Feed
        • 5.1.1.2.1. Vitamins and Minerals
        • 5.1.1.2.2. Amino Acids
        • 5.1.1.2.3. Acidifiers
        • 5.1.1.2.4. Others
  • 5.2. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Molluscs
      • 5.2.1.2. Shrimp
      • 5.2.1.3. Salmons
      • 5.2.1.4. Carps
      • 5.2.1.5. Tilapia
      • 5.2.1.6. Catfish
      • 5.2.1.7. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Pharmaceutical and Biologics
        • 6.1.1.1.1. Anti-infectives
        • 6.1.1.1.2. Parasiticides
        • 6.1.1.1.3. Biologics
        • 6.1.1.1.4. Others
      • 6.1.1.2. Medicated Feed
        • 6.1.1.2.1. Vitamins and Minerals
        • 6.1.1.2.2. Amino Acids
        • 6.1.1.2.3. Acidifiers
        • 6.1.1.2.4. Others
  • 6.2. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Molluscs
      • 6.2.1.2. Shrimp
      • 6.2.1.3. Salmons
      • 6.2.1.4. Carps
      • 6.2.1.5. Tilapia
      • 6.2.1.6. Catfish
      • 6.2.1.7. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 7.1. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Pharmaceutical and Biologics
        • 7.1.1.1.1. Anti-infectives
        • 7.1.1.1.2. Parasiticides
        • 7.1.1.1.3. Biologics
        • 7.1.1.1.4. Others
      • 7.1.1.2. Medicated Feed
        • 7.1.1.2.1. Vitamins and Minerals
        • 7.1.1.2.2. Amino Acids
        • 7.1.1.2.3. Acidifiers
        • 7.1.1.2.4. Others
  • 7.2. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Molluscs
      • 7.2.1.2. Shrimp
      • 7.2.1.3. Salmons
      • 7.2.1.4. Carps
      • 7.2.1.5. Tilapia
      • 7.2.1.6. Catfish
      • 7.2.1.7. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Pharmaceutical and Biologics
        • 8.1.1.1.1. Anti-infectives
        • 8.1.1.1.2. Parasiticides
        • 8.1.1.1.3. Biologics
        • 8.1.1.1.4. Others
      • 8.1.1.2. Medicated Feed
        • 8.1.1.2.1. Vitamins and Minerals
        • 8.1.1.2.2. Amino Acids
        • 8.1.1.2.3. Acidifiers
        • 8.1.1.2.4. Others
  • 8.2. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Molluscs
      • 8.2.1.2. Shrimp
      • 8.2.1.3. Salmons
      • 8.2.1.4. Carps
      • 8.2.1.5. Tilapia
      • 8.2.1.6. Catfish
      • 8.2.1.7. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Species Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Zoetis, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Schouw & Co
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Ridley Corporation Ltd
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Merck & Co Inc
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Biomin Holding GmbH
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Aller Aqua A/S
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Nutriad Ltd.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alltech Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Avanti Feeds Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Norel S.A.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Cargill, Incorporated
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Beneo GmbH
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Skretting AS
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations